Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Peng, Li-Xia"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 82
Tytuł:
Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis
Autorzy:
Chen Zhi-Yuan
Shi Ming
Peng Li-Xia
Wei Wei
Li Xin-Jian
Guo Zhi-Xing
Li Shu-Hong
Zhong Chong
Qian Chao-Nan
Guo Rong-Ping
Pokaż więcej
Temat:
Dovitinib
Endothelial cells
Hepatocellular carcinoma
Tumor growth
Tumor metastasis
Medicine
Źródło:
Journal of Translational Medicine, Vol 10, Iss 1, p 245 (2012)
Opis pliku:
electronic resource
Relacje:
http://www.translational-medicine.com/content/10/1/245; https://doaj.org/toc/1479-5876
Dostęp URL:
https://doaj.org/article/bb1b7969bac84e00a928351ab950e85d  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L.
Autorzy:
Yang, Guang-Da
Huang, Tie-Jun
Peng, Li-Xia
Yang, Chang-Fu
Liu, Ran-Yi
Huang, Hong-Bing
Chu, Qiao-Qiao
Yang, Hong-Jie
Huang, Jia-Ling
Zhu, Zhen-Yu
Qian, Chao-Nan
Huang, Bi-Jun
Pokaż więcej
Źródło:
PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-1. 1p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.
Autorzy:
Yang HJ
Huang TJ
Yang CF
Peng LX
Liu RY
Yang GD
Chu QQ
Huang JL
Liu N
Huang HB
Zhu ZY
Qian CN; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. .
Huang BJ
Pokaż więcej
Źródło:
Virology journal [Virol J] 2013 Oct 26; Vol. 10, pp. 314. Date of Electronic Publication: 2013 Oct 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Profiling*
Virus Latency*
Herpesvirus 4, Human/*genetics
Herpesvirus 4, Human/*physiology
MicroRNAs/*genetics
RNA, Viral/*genetics
Biopsy ; Cells, Cultured ; Humans ; Leukemia, Lymphoid/virology ; MicroRNAs/biosynthesis ; Microarray Analysis ; Neoplasms, Glandular and Epithelial/virology ; RNA, Viral/biosynthesis ; Real-Time Polymerase Chain Reaction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Downregulation of Ras Association Domain Family Member 6 (RASSF6) Underlies the Treatment Resistance of Highly Metastatic Nasopharyngeal Carcinoma Cells.
Autorzy:
Liang, Ying-Ying
Chen, Ming-Yuan
Hua, Yi-Jun
Chen, Shi
Zheng, Li-Sheng
Cao, Xue
Peng, Li-Xia
Xie, Ping
Huang, Bi-Jun
Sun, Rui
Wang, Lin
Xiang, Yan-Qun
Guo, Xiang
Qian, Chao-Nan
Pokaż więcej
Temat:
RAS oncogenes
NASOPHARYNX cancer
DRUG resistance in cancer cells
CISPLATIN
CANCER chemotherapy
CELL lines
CELLULAR signal transduction
CANCER treatment
Źródło:
PLoS ONE; Jul2014, Vol. 9 Issue 7, p1-9, 9p
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Autorzy:
Peng LX; Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Zhao P; Department of Breast Surgery, The Third Hospital Affiliated to Kunming Medical University, Kunming, Yunnan 650000, P.R. China.
Zhao HS; Department of General Surgery, The Second People's Hospital of Dehong, Dehong, Yunnan 678400, P.R. China.
Pan E; Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Yang BB; Department of Dermatology, The Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan 650000, P.R. China.
Li Q; Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2015 Dec; Vol. 12 (6), pp. 8275-81. Date of Electronic Publication: 2015 Oct 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents/*pharmacology
Bleomycin/*analogs & derivatives
Hemangioendothelioma/*metabolism
Phosphatidylinositol 3-Kinases/*physiology
Proto-Oncogene Proteins c-akt/*physiology
Animals ; Anti-Bacterial Agents/therapeutic use ; Apoptosis/drug effects ; Bleomycin/pharmacology ; Bleomycin/therapeutic use ; Cell Line ; Cell Proliferation/drug effects ; Hemangioendothelioma/drug therapy ; Hemangioendothelioma/pathology ; Mice ; Neoplasm Invasiveness/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Autorzy:
Meng DF; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Xie P; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Peng LX; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Sun R; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Luo DH; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Chen QY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Lv X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Wang L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Chen MY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Mai HQ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Guo L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Guo X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Zheng LS; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Cao L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yang JP; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Wang MY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Radiotherapy Department, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, 510095, China.
Mei Y; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Qiang YY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Zhang ZM; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yun JP; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Huang BJ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Qian CN; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2017 Jan 28; Vol. 36 (1), pp. 21. Date of Electronic Publication: 2017 Jan 28.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma/*pathology
ErbB Receptors/*metabolism
Microtubule-Associated Proteins/*genetics
Microtubule-Associated Proteins/*metabolism
Minor Histocompatibility Antigens/*genetics
Minor Histocompatibility Antigens/*metabolism
Nasopharyngeal Neoplasms/*pathology
Podosomes/*metabolism
Animals ; Carcinoma/genetics ; Carcinoma/metabolism ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice ; Mice, Nude ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms/genetics ; Nasopharyngeal Neoplasms/metabolism ; Neoplasm Invasiveness ; Neoplasm Transplantation ; Prognosis ; Signal Transduction ; Survival Analysis ; Wiskott-Aldrich Syndrome Protein, Neuronal/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Erratum to: CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Autorzy:
Meng DF; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Xie P; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Peng LX; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Sun R; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Luo DH; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Chen QY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Lv X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Wang L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Chen MY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Mai HQ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Guo L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Guo X; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Zheng LS; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Cao L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yang JP; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Wang MY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Radiotherapy Department, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, 510095, China.
Mei Y; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Qiang YY; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Zhang ZM; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yun JP; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.; Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Huang BJ; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Qian CN; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2017 Feb 20; Vol. 36 (1), pp. 33. Date of Electronic Publication: 2017 Feb 20.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Autorzy:
Qiang YY; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Li CZ; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Sun R; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zheng LS; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Peng LX; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Yang JP; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Meng DF; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Lang YH; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Mei Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Xie P; Department of Radiation Oncology, Longyan First Hospital, Affiliated to Fujian Medical University, Longyan, Fujian, China.
Xu L; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Cao Y; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Wei WW; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Cao L; Department of Pharmacy, Zhongshan People's Hospital, Zhongshan, Guangdong, China.
Hu H; Department of Traditional Chinese Medicine, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yang Q; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Luo DH; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Liang YY; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Huang BJ; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Qian CN; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, China. .; State Key Laboratory of Oncology in Southern China, Department of Experimental Research, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou, 510060, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 Feb 20; Vol. 37 (1), pp. 34. Date of Electronic Publication: 2018 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Chloride Channels/*metabolism
Extracellular Signal-Regulated MAP Kinases/*metabolism
Focal Adhesion Kinase 1/*metabolism
Nasopharyngeal Carcinoma/*metabolism
Nasopharyngeal Carcinoma/*pathology
Signal Transduction/*drug effects
Adult ; Aged ; Animals ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Survival/drug effects ; Chloride Channels/genetics ; Disease Models, Animal ; Epithelial-Mesenchymal Transition/drug effects ; Female ; Gene Expression ; Humans ; Male ; Mice ; Middle Aged ; Nasopharyngeal Carcinoma/drug therapy ; Nasopharyngeal Carcinoma/mortality ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Decreased macrophage inflammatory protein (MIP)-1α and MIP-1β increase the risk of developing nasopharyngeal carcinoma
Autorzy:
Yang, Meng-JieAff1, Aff2
Guo, JieAff1, Aff2, Aff3
Ye, Yan-Fang
Chen, Sui-HongAff1, Aff2
Peng, Li-XiaAff1, Aff5
Lin, Chu-YangAff1, Aff2
Hu, TingAff1, Aff2
Xie, Shang-HangAff1, Aff2
Xie, Chuan-BoAff1, Aff2
Huang, Qi-Hong
Lu, Yu-Qiang
Liu, QingAff1, Aff2
Qian, Chao-NanAff1, Aff5
Cao, Su-MeiAff1, Aff2
Pokaż więcej
Źródło:
Cancer Communications. 38(1)
Czasopismo naukowe
Szczegóły
Tytuł:
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Autorzy:
Lin F; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Xie YJ; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Medical University, Zhanjiang, 524023, People's Republic of China.
Zhang XK; Department of pathology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Huang TJ; Department of Nuclear Medicine, The Second People's Hospital of Shenzhen, Shenzhen, People's Republic of China.
Xu HF; Zhuhai Precision Medicine Center, Zhuhai People's Hospital Affiliated with Jinan University, Zhuhai, Guangdong, 519000, People's Republic of China.
Mei Y; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Liang H; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Hu H; Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510060, People's Republic of China.
Lin ST; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Luo FF; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Lang YH; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Peng LX; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Qian CN; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Huang BJ; State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 Apr 08; Vol. 38 (1), pp. 152. Date of Electronic Publication: 2019 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Microtubule-Associated Proteins/*metabolism
Tumor Suppressor Protein p53/*genetics
Tumor Suppressor Protein p53/*metabolism
Animals ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Cell Cycle/physiology ; Cell Differentiation/physiology ; Cell Line, Tumor ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; Heterografts ; Humans ; MCF-7 Cells ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Microtubule-Associated Proteins/biosynthesis ; Mutation ; Prognosis ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction ; Transfection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 82

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies